APO-Remifentanil remifentanil (as hydrochloride) 5 mg powder for injection vial

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

remifentanil hydrochloride, Quantity: 5.485 mg

Доступна з:

Arrotex Pharmaceuticals Pty Ltd

ІПН (Міжнародна Ім'я):

Remifentanil hydrochloride

Фармацевтична форма:

Injection, powder for

Склад:

Excipient Ingredients: glycine; hydrochloric acid

Адміністрація маршрут:

Intravenous Infusion

Одиниць в упаковці:

5 x 5 mg

Тип рецепту:

(S8) Controlled Drug

Терапевтичні свідчення:

Remifentanil is indicated:,- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures, including cardiac surgery, in adults;,- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical, but not cardiac procedures, in children aged 1?12 years;,- for continuation as an analgesic into the immediate post-operative period under the close supervision of medically-qualified persons trained in the use of anaesthetic agents, during transition to longer-acting analgesia following adult cardiac surgery ? when endotracheal intubation and controlled ventilation are anticipated;,- for provision of analgesia and sedation in mechanically-ventilated intensive care patients.

Огляд продуктів:

Visual Identification: White to off-white powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Статус Авторизація:

Licence status A

Дата Авторизація:

2016-01-06